Who owns ILUVIEN?
ILUVIEN is owned by ANI Pharmaceuticals (the United States, NASDAQ: ANIP), which has owned the brand since 16 September 2024.[1]
Evidence: ANI Pharmaceuticals, Inc. Annual Report on Form 10-K filed 2026-02-27, SEC EDGAR, 27 February 2026. Verified from filings; last checked .
Key facts
- Current owner
- ANI Pharmaceuticals, Inc. verified
- Owned since
- Owner HQ
- 🇺🇸 United States, Baudette
- Origin
- 🇺🇸 United States
- Category
- Healthcare & pharma › Drug makers › Pharmaceuticals
- Parent ticker
- NASDAQ: ANIP
- Last verified
- · 1 sources
About ILUVIEN
ILUVIEN is a fluocinolone acetonide intravitreal implant that ANI gained when it acquired Alimera Sciences on 16 September 2024. In March 2025 the FDA expanded its US label from diabetic macular edema to include chronic non-infectious uveitis affecting the posterior segment of the eye, and the 10-K says it was already approved for both uses in seventeen European countries. A contract manufacturer makes it.
Ownership timeline of ILUVIEN
- 2024 – present ANI Pharmaceuticals [1] verified
Where ILUVIEN sits in ANI Pharmaceuticals
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full ANI Pharmaceuticals ownership tree →
See the full ANI Pharmaceuticals brand portfolio (4) →
Other brands owned by ANI Pharmaceuticals
ANI Pharmaceuticals controls 4 brands on Brandtree, 4 of them in healthcare & pharma.
Also in healthcare & pharma
Other brands in pharmaceuticals, and who owns them
The 27 brands in pharmaceuticals on Brandtree belong to 10 owners. The largest is Teva, with 4; ANI Pharmaceuticals has 4.
About the owner: ANI Pharmaceuticals
ANI Pharmaceuticals is a publicly listed company headquartered in Baudette, United States. Brandtree records 4 brands under its control, and it is listed as NASDAQ: ANIP.
ANI Pharmaceuticals, Inc. is a Delaware corporation with its principal executive offices in Baudette, Minnesota. Its 10-K for 2025 calls it a diversified bio-pharmaceutical company that develops, manufactures and sells medicines through Rare Disease, Generics and Brands businesses, with a generics portfolio of more than 120 products and three owned manufacturing sites in Minnesota and New Jersey.
ANI Pharmaceuticals: full profile, brands and acquisition history →
🇺🇸 ILUVIEN and other American brands
Brandtree records a controlling owner for 2,549 brands that began in the United States. 478 of them (19%) are now controlled by a company headquartered in another country; ILUVIEN is not one of them.
Frequently asked questions
Who is the parent company of ILUVIEN?
The parent company of ILUVIEN is ANI Pharmaceuticals, a publicly listed company headquartered in the United States.
Is ILUVIEN American?
Yes. ILUVIEN originated in the United States and its owner, ANI Pharmaceuticals, is also headquartered in the United States.
Since when has ANI Pharmaceuticals owned ILUVIEN?
ANI Pharmaceuticals has owned ILUVIEN since 16 September 2024.
Is ILUVIEN still owned by ANI Pharmaceuticals?
Yes. As of 18 October 2026, ILUVIEN is still owned by ANI Pharmaceuticals. The ownership record was last checked against primary sources on that date.
Sources (1) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] ANI Pharmaceuticals, Inc. Annual Report on Form 10-K filed 2026-02-27 — SEC EDGAR, SEC Form 10-K, published 27 February 2026; retrieved 18 October 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.